Global Short Bowel Syndrome (SBS) Market Research Report 2024

Report ID: 1900118 | Published Date: Sep 2024 | No. of Page: 85 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Short Bowel Syndrome (SBS) Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Oral Route
        1.2.3 Parental Route
    1.3 Market by Sale Channel
        1.3.1 Global Short Bowel Syndrome (SBS) Market Share by Sale Channel: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Retail Pharmacies
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Short Bowel Syndrome (SBS) Market Perspective (2017-2028)
    2.2 Short Bowel Syndrome (SBS) Growth Trends by Region
        2.2.1 Short Bowel Syndrome (SBS) Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Short Bowel Syndrome (SBS) Historic Market Size by Region (2017-2022)
        2.2.3 Short Bowel Syndrome (SBS) Forecasted Market Size by Region (2023-2028)
    2.3 Short Bowel Syndrome (SBS) Market Dynamics
        2.3.1 Short Bowel Syndrome (SBS) Industry Trends
        2.3.2 Short Bowel Syndrome (SBS) Market Drivers
        2.3.3 Short Bowel Syndrome (SBS) Market Challenges
        2.3.4 Short Bowel Syndrome (SBS) Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Short Bowel Syndrome (SBS) Players by Revenue
        3.1.1 Global Top Short Bowel Syndrome (SBS) Players by Revenue (2017-2022)
        3.1.2 Global Short Bowel Syndrome (SBS) Revenue Market Share by Players (2017-2022)
    3.2 Global Short Bowel Syndrome (SBS) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Short Bowel Syndrome (SBS) Revenue
    3.4 Global Short Bowel Syndrome (SBS) Market Concentration Ratio
        3.4.1 Global Short Bowel Syndrome (SBS) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Short Bowel Syndrome (SBS) Revenue in 2021
    3.5 Short Bowel Syndrome (SBS) Key Players Head office and Area Served
    3.6 Key Players Short Bowel Syndrome (SBS) Product Solution and Service
    3.7 Date of Enter into Short Bowel Syndrome (SBS) Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Short Bowel Syndrome (SBS) Breakdown Data by Type
    4.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Type (2017-2022)
    4.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Type (2023-2028)
5 Short Bowel Syndrome (SBS) Breakdown Data by Sale Channel
    5.1 Global Short Bowel Syndrome (SBS) Historic Market Size by Sale Channel (2017-2022)
    5.2 Global Short Bowel Syndrome (SBS) Forecasted Market Size by Sale Channel (2023-2028)
6 North America
    6.1 North America Short Bowel Syndrome (SBS) Market Size (2017-2028)
    6.2 North America Short Bowel Syndrome (SBS) Market Size by Country (2017-2022)
    6.3 North America Short Bowel Syndrome (SBS) Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Short Bowel Syndrome (SBS) Market Size (2017-2028)
    7.2 Europe Short Bowel Syndrome (SBS) Market Size by Country (2017-2022)
    7.3 Europe Short Bowel Syndrome (SBS) Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Short Bowel Syndrome (SBS) Market Size (2017-2028)
    8.2 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Country (2017-2022)
    8.3 Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Short Bowel Syndrome (SBS) Market Size (2017-2028)
    9.2 Latin America Short Bowel Syndrome (SBS) Market Size by Country (2017-2022)
    9.3 Latin America Short Bowel Syndrome (SBS) Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Short Bowel Syndrome (SBS) Market Size (2017-2028)
    10.2 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2017-2022)
    10.3 Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Short Bowel Syndrome (SBS) Introduction
        11.1.4 Merck Revenue in Short Bowel Syndrome (SBS) Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 Takeda
        11.2.1 Takeda Company Detail
        11.2.2 Takeda Business Overview
        11.2.3 Takeda Short Bowel Syndrome (SBS) Introduction
        11.2.4 Takeda Revenue in Short Bowel Syndrome (SBS) Business (2017-2022)
        11.2.5 Takeda Recent Development
    11.3 Emmaus Medical
        11.3.1 Emmaus Medical Company Detail
        11.3.2 Emmaus Medical Business Overview
        11.3.3 Emmaus Medical Short Bowel Syndrome (SBS) Introduction
        11.3.4 Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Business (2017-2022)
        11.3.5 Emmaus Medical Recent Development
    11.4 Ardelyx
        11.4.1 Ardelyx Company Detail
        11.4.2 Ardelyx Business Overview
        11.4.3 Ardelyx Short Bowel Syndrome (SBS) Introduction
        11.4.4 Ardelyx Revenue in Short Bowel Syndrome (SBS) Business (2017-2022)
        11.4.5 Ardelyx Recent Development
    11.5 Naia Pharmaceuticals
        11.5.1 Naia Pharmaceuticals Company Detail
        11.5.2 Naia Pharmaceuticals Business Overview
        11.5.3 Naia Pharmaceuticals Short Bowel Syndrome (SBS) Introduction
        11.5.4 Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2017-2022)
        11.5.5 Naia Pharmaceuticals Recent Development
    11.6 Nutrinia
        11.6.1 Nutrinia Company Detail
        11.6.2 Nutrinia Business Overview
        11.6.3 Nutrinia Short Bowel Syndrome (SBS) Introduction
        11.6.4 Nutrinia Revenue in Short Bowel Syndrome (SBS) Business (2017-2022)
        11.6.5 Nutrinia Recent Development
    11.7 OxThera
        11.7.1 OxThera Company Detail
        11.7.2 OxThera Business Overview
        11.7.3 OxThera Short Bowel Syndrome (SBS) Introduction
        11.7.4 OxThera Revenue in Short Bowel Syndrome (SBS) Business (2017-2022)
        11.7.5 OxThera Recent Development
    11.8 Sancilio Pharmaceuticals
        11.8.1 Sancilio Pharmaceuticals Company Detail
        11.8.2 Sancilio Pharmaceuticals Business Overview
        11.8.3 Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Introduction
        11.8.4 Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2017-2022)
        11.8.5 Sancilio Pharmaceuticals Recent Development
    11.9 Zealand Pharma
        11.9.1 Zealand Pharma Company Detail
        11.9.2 Zealand Pharma Business Overview
        11.9.3 Zealand Pharma Short Bowel Syndrome (SBS) Introduction
        11.9.4 Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Business (2017-2022)
        11.9.5 Zealand Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Short Bowel Syndrome (SBS) Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Oral Route
    Table 3. Key Players of Parental Route
    Table 4. Global Short Bowel Syndrome (SBS) Market Size Growth by Sale Channel (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Short Bowel Syndrome (SBS) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Short Bowel Syndrome (SBS) Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Short Bowel Syndrome (SBS) Market Share by Region (2017-2022)
    Table 8. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Short Bowel Syndrome (SBS) Market Share by Region (2023-2028)
    Table 10. Short Bowel Syndrome (SBS) Market Trends
    Table 11. Short Bowel Syndrome (SBS) Market Drivers
    Table 12. Short Bowel Syndrome (SBS) Market Challenges
    Table 13. Short Bowel Syndrome (SBS) Market Restraints
    Table 14. Global Short Bowel Syndrome (SBS) Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Short Bowel Syndrome (SBS) Market Share by Players (2017-2022)
    Table 16. Global Top Short Bowel Syndrome (SBS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) as of 2021)
    Table 17. Ranking of Global Top Short Bowel Syndrome (SBS) Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Short Bowel Syndrome (SBS) Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Short Bowel Syndrome (SBS) Product Solution and Service
    Table 21. Date of Enter into Short Bowel Syndrome (SBS) Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Short Bowel Syndrome (SBS) Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2017-2022)
    Table 25. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Short Bowel Syndrome (SBS) Revenue Market Share by Type (2023-2028)
    Table 27. Global Short Bowel Syndrome (SBS) Market Size by Sale Channel (2017-2022) & (US$ Million)
    Table 28. Global Short Bowel Syndrome (SBS) Revenue Market Share by Sale Channel (2017-2022)
    Table 29. Global Short Bowel Syndrome (SBS) Forecasted Market Size by Sale Channel (2023-2028) & (US$ Million)
    Table 30. Global Short Bowel Syndrome (SBS) Revenue Market Share by Sale Channel (2023-2028)
    Table 31. North America Short Bowel Syndrome (SBS) Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Short Bowel Syndrome (SBS) Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Short Bowel Syndrome (SBS) Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Short Bowel Syndrome (SBS) Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Short Bowel Syndrome (SBS) Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Short Bowel Syndrome (SBS) Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Short Bowel Syndrome (SBS) Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Short Bowel Syndrome (SBS) Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Merck Company Detail
    Table 42. Merck Business Overview
    Table 43. Merck Short Bowel Syndrome (SBS) Product
    Table 44. Merck Revenue in Short Bowel Syndrome (SBS) Business (2017-2022) & (US$ Million)
    Table 45. Merck Recent Development
    Table 46. Takeda Company Detail
    Table 47. Takeda Business Overview
    Table 48. Takeda Short Bowel Syndrome (SBS) Product
    Table 49. Takeda Revenue in Short Bowel Syndrome (SBS) Business (2017-2022) & (US$ Million)
    Table 50. Takeda Recent Development
    Table 51. Emmaus Medical Company Detail
    Table 52. Emmaus Medical Business Overview
    Table 53. Emmaus Medical Short Bowel Syndrome (SBS) Product
    Table 54. Emmaus Medical Revenue in Short Bowel Syndrome (SBS) Business (2017-2022) & (US$ Million)
    Table 55. Emmaus Medical Recent Development
    Table 56. Ardelyx Company Detail
    Table 57. Ardelyx Business Overview
    Table 58. Ardelyx Short Bowel Syndrome (SBS) Product
    Table 59. Ardelyx Revenue in Short Bowel Syndrome (SBS) Business (2017-2022) & (US$ Million)
    Table 60. Ardelyx Recent Development
    Table 61. Naia Pharmaceuticals Company Detail
    Table 62. Naia Pharmaceuticals Business Overview
    Table 63. Naia Pharmaceuticals Short Bowel Syndrome (SBS) Product
    Table 64. Naia Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2017-2022) & (US$ Million)
    Table 65. Naia Pharmaceuticals Recent Development
    Table 66. Nutrinia Company Detail
    Table 67. Nutrinia Business Overview
    Table 68. Nutrinia Short Bowel Syndrome (SBS) Product
    Table 69. Nutrinia Revenue in Short Bowel Syndrome (SBS) Business (2017-2022) & (US$ Million)
    Table 70. Nutrinia Recent Development
    Table 71. OxThera Company Detail
    Table 72. OxThera Business Overview
    Table 73. OxThera Short Bowel Syndrome (SBS) Product
    Table 74. OxThera Revenue in Short Bowel Syndrome (SBS) Business (2017-2022) & (US$ Million)
    Table 75. OxThera Recent Development
    Table 76. Sancilio Pharmaceuticals Company Detail
    Table 77. Sancilio Pharmaceuticals Business Overview
    Table 78. Sancilio Pharmaceuticals Short Bowel Syndrome (SBS) Product
    Table 79. Sancilio Pharmaceuticals Revenue in Short Bowel Syndrome (SBS) Business (2017-2022) & (US$ Million)
    Table 80. Sancilio Pharmaceuticals Recent Development
    Table 81. Zealand Pharma Company Detail
    Table 82. Zealand Pharma Business Overview
    Table 83. Zealand Pharma Short Bowel Syndrome (SBS) Product
    Table 84. Zealand Pharma Revenue in Short Bowel Syndrome (SBS) Business (2017-2022) & (US$ Million)
    Table 85. Zealand Pharma Recent Development
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Short Bowel Syndrome (SBS) Market Share by Type: 2021 VS 2028
    Figure 2. Oral Route Features
    Figure 3. Parental Route Features
    Figure 4. Global Short Bowel Syndrome (SBS) Market Share by Sale Channel in 2021 & 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Retail Pharmacies Case Studies
    Figure 8. Short Bowel Syndrome (SBS) Report Years Considered
    Figure 9. Global Short Bowel Syndrome (SBS) Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Short Bowel Syndrome (SBS) Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Short Bowel Syndrome (SBS) Market Share by Region: 2021 VS 2028
    Figure 12. Global Short Bowel Syndrome (SBS) Market Share by Players in 2021
    Figure 13. Global Top Short Bowel Syndrome (SBS) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Short Bowel Syndrome (SBS) as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Short Bowel Syndrome (SBS) Revenue in 2021
    Figure 15. North America Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 16. North America Short Bowel Syndrome (SBS) Market Share by Country (2017-2028)
    Figure 17. United States Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Canada Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Short Bowel Syndrome (SBS) Market Share by Country (2017-2028)
    Figure 21. Germany Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. France Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. U.K. Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Italy Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Russia Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Nordic Countries Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Short Bowel Syndrome (SBS) Market Share by Region (2017-2028)
    Figure 29. China Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Japan Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. South Korea Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Southeast Asia Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. India Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Australia Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Short Bowel Syndrome (SBS) Market Share by Country (2017-2028)
    Figure 37. Mexico Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Brazil Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Short Bowel Syndrome (SBS) Market Share by Country (2017-2028)
    Figure 41. Turkey Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Saudi Arabia Short Bowel Syndrome (SBS) Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Merck Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2017-2022)
    Figure 44. Takeda Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2017-2022)
    Figure 45. Emmaus Medical Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2017-2022)
    Figure 46. Ardelyx Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2017-2022)
    Figure 47. Naia Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2017-2022)
    Figure 48. Nutrinia Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2017-2022)
    Figure 49. OxThera Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2017-2022)
    Figure 50. Sancilio Pharmaceuticals Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2017-2022)
    Figure 51. Zealand Pharma Revenue Growth Rate in Short Bowel Syndrome (SBS) Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Merck
Takeda
Emmaus Medical
Ardelyx
Naia Pharmaceuticals
Nutrinia
OxThera
Sancilio Pharmaceuticals
Zealand Pharma
Frequently Asked Questions
Short Bowel Syndrome (SBS) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Short Bowel Syndrome (SBS) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Short Bowel Syndrome (SBS) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports